• Je něco špatně v tomto záznamu ?

Expanded DMPK repeats in dizygotic twins referred for diagnosis of autism versus absence of expanded DMPK repeats at screening of 330 children with autism

Musova Z, Hancarova M, Havlovicova M, Pourova R, Hrdlicka M, Kraus J, Trkova M, Stejskal D, Sedlacek Z

. 2016 ; 12 () : 2367-2372.

Jazyk angličtina Země Nový Zéland

Perzistentní odkaz   https://www.medvik.cz/link/bmc19032051

Grantová podpora
NT14200 MZ0 CEP - Centrální evidence projektů

Myotonic dystrophy type 1 (DM1) belongs to the broad spectrum of genetic disorders associated with autism spectrum disorders (ASD). ASD were reported predominantly in congenital and early childhood forms of DM1. We describe dizygotic twin boys with ASD who were referred for routine laboratory genetic testing and in whom karyotyping, FMR1 gene testing, and single nucleotide polymorphism array analysis yielded negative results. The father of the boys was later diagnosed with suspected DM1, and testing revealed characteristic DMPK gene expansions in his genome as well as in the genomes of both twins and their elder brother, who also suffered from ASD. In accord with previous reports on childhood forms of DM1, our patients showed prominent neuropsychiatric phenotypes characterized especially by hypotonia, developmental and language delay, emotional and affective lability, lowered adaptability, and social withdrawal. The experience with this family and multiple literature reports of ASD in DM1 on the one side but the lack of literature data on the frequency of DMPK gene expansions in ASD patients on the other side prompted us to screen the DMPK gene in a sample of 330 patients with ASD who were first seen by a geneticist before they were 10 years of age, before the muscular weakness, which may signal DM1, usually becomes obvious. The absence of any DMPK gene expansions in this cohort indicates that targeted DMPK gene testing can be recommended only in ASD patients with specific symptoms or family history suggestive of DM1.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19032051
003      
CZ-PrNML
005      
20200130105700.0
007      
ta
008      
190918s2016 nz f 000 0|eng||
009      
AR
024    7_
$a 10.2147/NDT.S113917 $2 doi
035    __
$a (Pubmed)27695335
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a nz
100    1_
$a Musova Z, Hancarova M, Havlovicova M, Pourova R, Hrdlicka M, Kraus J, Trkova M, Stejskal D, Sedlacek Z $u Department of Biology and Medical Genetics, Charles University 2nd Faculty of Medicine and University Hospital Motol
245    10
$a Expanded DMPK repeats in dizygotic twins referred for diagnosis of autism versus absence of expanded DMPK repeats at screening of 330 children with autism / $c Musova Z, Hancarova M, Havlovicova M, Pourova R, Hrdlicka M, Kraus J, Trkova M, Stejskal D, Sedlacek Z
520    9_
$a Myotonic dystrophy type 1 (DM1) belongs to the broad spectrum of genetic disorders associated with autism spectrum disorders (ASD). ASD were reported predominantly in congenital and early childhood forms of DM1. We describe dizygotic twin boys with ASD who were referred for routine laboratory genetic testing and in whom karyotyping, FMR1 gene testing, and single nucleotide polymorphism array analysis yielded negative results. The father of the boys was later diagnosed with suspected DM1, and testing revealed characteristic DMPK gene expansions in his genome as well as in the genomes of both twins and their elder brother, who also suffered from ASD. In accord with previous reports on childhood forms of DM1, our patients showed prominent neuropsychiatric phenotypes characterized especially by hypotonia, developmental and language delay, emotional and affective lability, lowered adaptability, and social withdrawal. The experience with this family and multiple literature reports of ASD in DM1 on the one side but the lack of literature data on the frequency of DMPK gene expansions in ASD patients on the other side prompted us to screen the DMPK gene in a sample of 330 patients with ASD who were first seen by a geneticist before they were 10 years of age, before the muscular weakness, which may signal DM1, usually becomes obvious. The absence of any DMPK gene expansions in this cohort indicates that targeted DMPK gene testing can be recommended only in ASD patients with specific symptoms or family history suggestive of DM1.
650    12
$a autistická porucha $x genetika $7 D001321
650    12
$a myotonická dystrofie $7 D009223
650    12
$a DM-kinasa $7 D065636
650    12
$a genetické testování $7 D005820
650    _2
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a lidé $7 D006801
650    _2
$a dítě $7 D002648
650    _2
$a kohortové studie $7 D015331
650    _2
$a dvojčata dizygotní $7 D014429
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a předškolní dítě $7 D002675
650    _2
$a ženské pohlaví $7 D005260
700    1_
$a Hančárová, Miroslava $7 xx0275406 $u Department of Biology and Medical Genetics, Charles University 2nd Faculty of Medicine and University Hospital Motol
700    1_
$a Havlovicová, Markéta $7 xx0066532 $u Department of Biology and Medical Genetics, Charles University 2nd Faculty of Medicine and University Hospital Motol
700    1_
$a Kremlíková Pourová, Radka $7 xx0160300 $u Department of Biology and Medical Genetics, Charles University 2nd Faculty of Medicine and University Hospital Motol
700    1_
$a Hrdlička, Michal, $d 1965- $7 jn99240000325 $u Department of Child Psychiatry, Charles University 2nd Faculty of Medicine and University Hospital Motol
700    1_
$a Kraus, Josef, $d 1951- $7 mzk2004261109 $u Department of Child Neurology, Charles University 2nd Faculty of Medicine and University Hospital Motol
700    1_
$a Trková, Marie $7 xx0164107 $u Gennet, Centre for Fetal Medicine, Prague, Czech Republic.
700    1_
$a Stejskal, David, $d 1950- $7 xx0142070 $u Gennet, Centre for Fetal Medicine, Prague, Czech Republic.
700    1_
$a Sedláček, Zdeněk, $d 1960- $7 skuk0005184 $u Department of Biology and Medical Genetics, Charles University 2nd Faculty of Medicine and University Hospital Motol
773    0_
$t Neuropsychiatric disease and treatment $x 1176-6328 $g Roč. 12(2016), s. 2367-2372 $w MED00183034
910    __
$a ABA008 $b sig $y p $z 0
990    __
$a 20190918104049 $b ABA008
991    __
$a 20200130110043 $b ABA008
999    __
$a ok $b bmc $g 1444452 $s 1070555
BAS    __
$a 3
BMC    __
$a 2016 $b 12 $d 2367-2372 $x MED00183034 $i 1176-6328 $m Neuropsychiatric disease and treatment
GRA    __
$a NT14200 $p MZ0
LZP    __
$a NLK 2019/lp

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...